Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial. [electronic resource]
Producer: 20120321Description: 1819-26 p. digitalISSN:- 1539-2864
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Bevacizumab
- Drug Therapy, Combination
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Glucocorticoids -- therapeutic use
- Humans
- Intravitreal Injections
- Male
- Middle Aged
- Prospective Studies
- Retreatment
- Tomography, Optical Coherence
- Treatment Outcome
- Triamcinolone Acetonide -- therapeutic use
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
- Wet Macular Degeneration -- diagnosis
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.